[Immunohistochemical and serological demonstration of thyreoglobulin tissue polypeptide antigen, carcinoembryonic antigen and calcitonin in diversely differentiated thyroid gland carcinomas and thyroid gland adenomas].
D000230:Adenocarcinoma / Q000276:immunology; D000236:Adenoma / Q000276:immunology; D002116:Calcitonin / Q000032:analysis* / Q000097:blood; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D002277:Carcinoma / Q000276:immunology; D002291:Carcinoma, Papillary / Q000276:immunology; D003537:Cystadenoma / Q000276:immunology; D003937:Diagnosis, Differential; D006801:Humans; D007124:Immunoenzyme Techniques; D010455:Peptides / Q000032:analysis*; D013954:Thyroglobulin / Q000032:analysis* / Q000097:blood; D013964:Thyroid Neoplasms / Q000175:diagnosis / Q000276:immunology*; D019396:Tissue Polypeptide Antigen
D002272:Carcinoembryonic Antigen; D010455:Peptides; D019396:Tissue Polypeptide Antigen; D002116:Calcitonin; D013954:Thyroglobulin
Immunhistochemischer und serologischer Nachweis von Thyreoglobulin (hTG), Tissue Polypeptide Antigen (TPA), karzinoembryonalem Antigen (CEA) und Calcitonin (CT) bei unterschiedlich differenzierten Schilddrüsenkarzinomen und Schilddrüsenadenomen.